Key Takeaways:
- President Donald Trump signed an executive order to reclassify cannabis from a Schedule I to a Schedule III drug, allowing for expanded access and research on its potential medical benefits.
- The reclassification will not legalize marijuana for recreational use under federal law, but it will provide tax breaks for cannabis businesses and allow them to deduct operating expenses.
- The move is seen as a significant step towards broader acceptance of marijuana on a national scale, with potential benefits for consumers, businesses, and researchers.
- Colorado’s marijuana industry is expected to benefit from the change, with potential tax savings and increased access to banking and financial services.
- However, some health experts and researchers have raised concerns about the potential risks and lack of research on the effects of high-potency THC products.
Introduction to the Executive Order
President Donald Trump’s executive order to reclassify cannabis from a Schedule I to a Schedule III drug has been met with a mix of praise and concern from various stakeholders. The move is seen as a significant step towards broader acceptance of marijuana on a national scale, with potential benefits for consumers, businesses, and researchers. However, some health experts and researchers have raised concerns about the potential risks and lack of research on the effects of high-potency THC products. According to attorney Brian Vicente, one of the authors of the amendment that legalized recreational marijuana in Colorado, the reclassification would be the biggest thing to happen for Colorado’s marijuana atmosphere since legalization.
Response to the Executive Order
The response to the executive order has been largely positive from Colorado’s politicians, with Governor Jared Polis applauding the move as a good first step, but also calling for further action to fully decriminalize marijuana. Members of Colorado’s congressional delegation from both parties have also praised the decision, with Democratic Rep. Brittany Pettersen noting that criminalizing people for using marijuana is "absolutely horrific" and that the move is a step in the right direction. However, some congressional Republicans have opposed the move, citing concerns about the potential risks and lack of research on the effects of marijuana. Republican Colorado Rep. Lauren Boebert stated that while she does not like the direction Colorado has gone since cannabis was first legalized, regulations on banking need to be changed, and she is open to rescheduling it to reduce the number of people serving time in prison for marijuana-related offenses.
Health and Research Implications
The reaction in Colorado’s health and research communities has been mixed, with some experts expressing concerns about the potential risks and lack of research on the effects of high-potency THC products. Diane Carlson, co-founder and national policy director of the organization One Chance to Grow Up, noted that the potency of THC has tripled since the 1990s and that Dutch health experts have concluded that THC potency above 15% classifies it as a hard drug. Colorado has mandated education about high-concentration THC, and the state health department has posted educational resources and information for providers on an agency webpage. Cathy Bradley, dean of the Colorado School of Public Health, wished that more research had been done over many years to inform policymakers before they make sweeping changes. Gregory Tung, an associate professor at the Colorado School of Public Health, called for policies informed by research to thread the needle between health benefits and harms.
Impact on Colorado Businesses
The reclassification of cannabis is expected to have a significant impact on Colorado businesses, particularly in the marijuana industry. Ryan Hunter, chief revenue officer of Aurora-based cannabis brand Spherex, noted that the change to the tax code would save his company millions of dollars per year and make them more profitable overnight. The tax break would be a major boon at a time when cannabis sales are declining in Colorado, due in part to competition from other states and online sales of hemp products. Hunter also noted that doctors may be more likely to prescribe cannabis as a Schedule III substance, and that there may be a segment of consumers who feel more comfortable consuming cannabis as a medication.
Conclusion and Future Developments
The reclassification of cannabis is a developing story, and it remains to be seen how the move will play out in terms of its impact on consumers, businesses, and researchers. While some experts have raised concerns about the potential risks and lack of research on the effects of high-potency THC products, others see the move as a significant step towards broader acceptance of marijuana on a national scale. As the situation continues to evolve, it will be important to monitor the effects of the reclassification and to ensure that policies are informed by research and prioritizing public health and safety. Additionally, Congress will need to act to deschedule cannabis completely, which would have a more significant impact on the industry.
/file/dailymaverick/wp-content/uploads/2025/07/PHOTO-2025-06-10-14-44-52.jpg?w=300&resize=300,300&ssl=1 "Joburg Enters Second Phase of Water Maintenance Amid Ongoing Recovery")
